Press Release: ViiV Healthcare : Quebec becomes first province to publicly reimburse APRETUDE for HIV-1 Pre-Exposure Prophylaxis (PrEP)
/CNW/ - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi as shareholders, is...
Read full article »
ViiV Healthcare is an England-based biotechnological company that develops and commercializes therapeutics for the treatment of HIV/AIDS.
Read more